AstraZeneca strikes $1bn deal to acquire first vaccine company
Published
UK pharma group agrees to buy Seattle-based biotech Icosavax
Full ArticlePublished
UK pharma group agrees to buy Seattle-based biotech Icosavax
Full ArticleAstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up..